Johnson & Johnson

JNJ · NYSE · Stock · Healthcare
$252.45
+1.54% today
Delayed price,

What Johnson & Johnson does

Johnson & Johnson, together with its subsidiaries, engages in the research and development, manufacture, and sale of a range of products in the healthcare field worldwide. It operates in two segments, Innovative Medicine and MedTech. The Innovative Medicine segment offers products for various therapeutic areas, such as oncology, immunology, neuroscience, pulmonary hypertension, infectious diseases, and cardiovascular and metabolism distributed through retailers, wholesalers, distributors, hospitals, and healthcare professionals for prescription use. The MedTech segment provides a portfolio of products used in the surgery, orthopedic, cardiovascular, and vision fields distributed through wholesalers, hospitals and retailers, and used in the professional fields by physicians, nurses, hospitals, eye care professionals and clinics. This segment also offers products and enabling technologies that support joint reconstruction, trauma, spine, sports related injuries, and others, as well as open, laparoscopic, and robotic surgical procedures; instrumentation, energy devices, stapling systems, wound closure, biosurgery products, and digital and robotic technologies; breast aesthetics and reconstruction; contact lenses under the ACUVUE brand; intraocular lenses for cataract surgery, and other products used in cataract and refractive procedures under the TECNIS brand. The company was founded in 1886 and is based in New Brunswick, New Jersey.

Key facts

Sector
Healthcare
Industry
Drug Manufacturers - General
Market cap
$608.38B
P/E (ttm)
29.3
Forward P/E
21.4
Dividend yield
2.16%
Beta
0.21
Profit margin
21.5%
Employees
138,200
Headquarters
New Brunswick, NJ, United States
Exchange
NYSE

Performance

1 Month
-6.5%
3 Months
-0.2%
6 Months
+7.8%
1 Year
+30.7%
5 Years
+61.9%
$184.6652-week range$281.07
Biggest setback — last 12 months
-10.9%
23 Feb 2026 → 4 May 2026
Fell from $248.43 to $221.32 — its sharpest sustained decline this year.
Biggest run-up — last 12 months
+47.5%
3 Nov 2025 → 31 Aug 2026
Ran from $186.57 to $275.23 — its strongest sustained advance this year.

Price outlook — trend & volatility model

● Trend: Above long-term trend
Price sits above its 200-day average, but the shorter-term averages are not cleanly aligned above/below it.
HorizonBear case (−1σ)Base caseBull case (+1σ)
1 Month$237.41 (-6.0%)$252.45$268.45 (+6.3%)
3 Months$226.96 (-10.1%)$252.45$280.80 (+11.2%)
6 Months$217.18 (-14.0%)$252.45$293.45 (+16.2%)
12 Months$204.05 (-19.2%)$252.45$312.33 (+23.7%)
Statistical, not machine-learning: a random-walk (no assumed drift) volatility model built from this ticker's own realized price history, plus a purely descriptive moving-average trend read. Illustrative only — not a price target and not financial advice. The bear and bull cases sit one standard deviation (1σ) below and above today's price, a range that covers about 68% of the outcomes the model treats as plausible, not a 68% chance of either case. Annualized volatility used: 21.3%, blended from this ticker's own 3-month and 1-year realized price history. Base case is deliberately flat — this quantifies a possible range, not a directional prediction. See the full model, including wider (≈95%) bands →

Comparable companies

Recent headlines

Learn the basics

Prices and company data are delayed reference figures from public sources (Yahoo Finance, SEC EDGAR) and may be inaccurate or out of date. This page is informational only — it is not investment advice or a recommendation to buy or sell any security. Past performance does not indicate future results.